Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities

Yuejia Xu, Oliver B. Laeyendecker, Rui Wang

Research output: Contribution to journalArticle

Abstract

Accurate estimation of human immunodeficiency virus (HIV) incidence rates is crucial for the monitoring of HIV epidemics, the evaluation of prevention programs, and the design of prevention studies. Traditional cohort approaches to measure HIV incidence require repeatedly testing large cohorts of HIV-uninfected individuals with an HIV diagnostic test (eg, enzyme-linked immunosorbent assay) for long periods of time to identify new infections, which can be prohibitively costly, time-consuming, and subject to loss to follow-up. Cross-sectional approaches based on the usual HIV diagnostic test and biomarkers of recent infection offer important advantages over standard cohort approaches, in terms of time, cost, and attrition. Cross-sectional samples usually consist of individuals from different communities. However, small sample sizes limit the ability to estimate community-specific incidence and existing methods typically ignore heterogeneity in incidence across communities. We propose a permutation test for the null hypothesis of no heterogeneity in incidence rates across communities, develop a random-effects model to account for this heterogeneity and to estimate community-specific incidence, and provide one way to estimate the coefficient of variation. We evaluate the performance of the proposed methods through simulation studies and apply them to the data from the National Institute of Mental Health Project ACCEPT, a phase 3 randomized controlled HIV prevention trial in Sub-Saharan Africa, to estimate the overall and community-specific HIV incidence rates.

Original languageEnglish (US)
Pages (from-to)1017-1028
Number of pages12
JournalBiometrics
Volume75
Issue number3
DOIs
StatePublished - Sep 1 2019

Fingerprint

Human immunodeficiency virus
Viruses
Virus
Incidence
HIV
incidence
Diagnostic Tests
Routine Diagnostic Tests
Estimate
diagnostic techniques
Infection
National Institute of Mental Health (U.S.)
Enzyme-linked Immunosorbent Assay
Attrition
Immunosorbents
Permutation Test
mental health
Community
Human
Coefficient of variation

Keywords

  • biomarkers
  • coefficient of variation
  • permutation test
  • random-effects model

ASJC Scopus subject areas

  • Statistics and Probability
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)
  • Applied Mathematics

Cite this

Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities. / Xu, Yuejia; Laeyendecker, Oliver B.; Wang, Rui.

In: Biometrics, Vol. 75, No. 3, 01.09.2019, p. 1017-1028.

Research output: Contribution to journalArticle

@article{9886af32217f4728a35be6a1bde898ef,
title = "Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities",
abstract = "Accurate estimation of human immunodeficiency virus (HIV) incidence rates is crucial for the monitoring of HIV epidemics, the evaluation of prevention programs, and the design of prevention studies. Traditional cohort approaches to measure HIV incidence require repeatedly testing large cohorts of HIV-uninfected individuals with an HIV diagnostic test (eg, enzyme-linked immunosorbent assay) for long periods of time to identify new infections, which can be prohibitively costly, time-consuming, and subject to loss to follow-up. Cross-sectional approaches based on the usual HIV diagnostic test and biomarkers of recent infection offer important advantages over standard cohort approaches, in terms of time, cost, and attrition. Cross-sectional samples usually consist of individuals from different communities. However, small sample sizes limit the ability to estimate community-specific incidence and existing methods typically ignore heterogeneity in incidence across communities. We propose a permutation test for the null hypothesis of no heterogeneity in incidence rates across communities, develop a random-effects model to account for this heterogeneity and to estimate community-specific incidence, and provide one way to estimate the coefficient of variation. We evaluate the performance of the proposed methods through simulation studies and apply them to the data from the National Institute of Mental Health Project ACCEPT, a phase 3 randomized controlled HIV prevention trial in Sub-Saharan Africa, to estimate the overall and community-specific HIV incidence rates.",
keywords = "biomarkers, coefficient of variation, permutation test, random-effects model",
author = "Yuejia Xu and Laeyendecker, {Oliver B.} and Rui Wang",
year = "2019",
month = "9",
day = "1",
doi = "10.1111/biom.13046",
language = "English (US)",
volume = "75",
pages = "1017--1028",
journal = "Biometrics",
issn = "0006-341X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities

AU - Xu, Yuejia

AU - Laeyendecker, Oliver B.

AU - Wang, Rui

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Accurate estimation of human immunodeficiency virus (HIV) incidence rates is crucial for the monitoring of HIV epidemics, the evaluation of prevention programs, and the design of prevention studies. Traditional cohort approaches to measure HIV incidence require repeatedly testing large cohorts of HIV-uninfected individuals with an HIV diagnostic test (eg, enzyme-linked immunosorbent assay) for long periods of time to identify new infections, which can be prohibitively costly, time-consuming, and subject to loss to follow-up. Cross-sectional approaches based on the usual HIV diagnostic test and biomarkers of recent infection offer important advantages over standard cohort approaches, in terms of time, cost, and attrition. Cross-sectional samples usually consist of individuals from different communities. However, small sample sizes limit the ability to estimate community-specific incidence and existing methods typically ignore heterogeneity in incidence across communities. We propose a permutation test for the null hypothesis of no heterogeneity in incidence rates across communities, develop a random-effects model to account for this heterogeneity and to estimate community-specific incidence, and provide one way to estimate the coefficient of variation. We evaluate the performance of the proposed methods through simulation studies and apply them to the data from the National Institute of Mental Health Project ACCEPT, a phase 3 randomized controlled HIV prevention trial in Sub-Saharan Africa, to estimate the overall and community-specific HIV incidence rates.

AB - Accurate estimation of human immunodeficiency virus (HIV) incidence rates is crucial for the monitoring of HIV epidemics, the evaluation of prevention programs, and the design of prevention studies. Traditional cohort approaches to measure HIV incidence require repeatedly testing large cohorts of HIV-uninfected individuals with an HIV diagnostic test (eg, enzyme-linked immunosorbent assay) for long periods of time to identify new infections, which can be prohibitively costly, time-consuming, and subject to loss to follow-up. Cross-sectional approaches based on the usual HIV diagnostic test and biomarkers of recent infection offer important advantages over standard cohort approaches, in terms of time, cost, and attrition. Cross-sectional samples usually consist of individuals from different communities. However, small sample sizes limit the ability to estimate community-specific incidence and existing methods typically ignore heterogeneity in incidence across communities. We propose a permutation test for the null hypothesis of no heterogeneity in incidence rates across communities, develop a random-effects model to account for this heterogeneity and to estimate community-specific incidence, and provide one way to estimate the coefficient of variation. We evaluate the performance of the proposed methods through simulation studies and apply them to the data from the National Institute of Mental Health Project ACCEPT, a phase 3 randomized controlled HIV prevention trial in Sub-Saharan Africa, to estimate the overall and community-specific HIV incidence rates.

KW - biomarkers

KW - coefficient of variation

KW - permutation test

KW - random-effects model

UR - http://www.scopus.com/inward/record.url?scp=85072057621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072057621&partnerID=8YFLogxK

U2 - 10.1111/biom.13046

DO - 10.1111/biom.13046

M3 - Article

C2 - 30746695

AN - SCOPUS:85072057621

VL - 75

SP - 1017

EP - 1028

JO - Biometrics

JF - Biometrics

SN - 0006-341X

IS - 3

ER -